EGFR and breast carcinoma: In addition, E2 signaling to ERK 1/2 was dependent upon the transactivation of the EGFR via the release of membrane-associated heparin-bound EGF (HB-EGF) in MDA-MB231 cells, which are ER- breast cancer cells [30].